Xpert MTB/RIF Test in the Diagnosis of Pulmonary Tuberculosis
Pulmonary Tuberculosis Confirmation by Culture
About this trial
This is an interventional diagnostic trial for Pulmonary Tuberculosis Confirmation by Culture focused on measuring Tuberculosis, Xpert MTB/RIF, diagnostic turnaround time
Eligibility Criteria
Inclusion Criteria:
- All presumptive tuberculosis cases who have sputum examinations for the diagnosis of pulmonary TB
Exclusion Criteria:
- Tuberculosis cases who have been on treatment for 14 or more days who have sputum examinations for follow-up
Sites / Locations
- Chang-Hua Hospital
- Buddhist Tzu Chi General Hospital
- Taichung Veterans General Hospital
- Chest Hospital, Ministry of Health and Welfare
- Wan Fang Hospital, Taipei Medical University
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Experimental
No Intervention
Immediate NAA by clinician
Immediate NAA as intervention
No immediate NAA
Nucleic acid amplification test requested by clinicians as the initial diagnostic test for the diagnosis of pulmonary TB
Nucleic acid amplification test not requested by clinicians as the initial diagnostic test for the diagnosis of pulmonary TB, but Xpert MTB/RIF is performed as intervention in this study (intervention group)
Nucleic acid amplification test not requested by clinicians as the initial diagnostic test for the diagnosis of pulmonary TB, and Xpert MTB/RIF is not performed as the initial diagnostic test in this study (control group). Nucleic acid amplification test may be ordered at a later point in time by clinicians as an add-on test after sputum smear microscopy